Migrevention OÜ

Migrevention OÜ was established as a need-driven digital health company in 2020. The team of Migrevention consists of diverse migraine experts from headache patients to Estonias top medical specialists. The main product of Migrevention, a digital headache clinic, is a digital health tool based on the International Headache Standard and multidisciplinary headache treatment approach. The digital headache clinic is composed of patients mobile applications that allow the patient to use a headache diary and remotely monitored evidence-based migraine treatment. Migrevention also offers a specialist dashboard from where the patients can be monitored, treatment addressed and treatment changes easily made.

Quretec OÜ

Quretec OÜ was established in 2006 as a software company building upon unique skills in data management solutions. The team was established in 2002 as an IT department of EGeen, a venture that started with a goal to collect and analyse DNA samples of the Estonian population for drug discovery and personalized medicine development purposes. Since 2006 Quretec has acted as a privately held company, providing innovative software development and data management services (bioinformatics, biostatistics, etc.).

Project's goal

The main goal of the project is to increase the availability of multimodal evidence-based migraine treatment by establishing a fully digital and cost-effective digital headache clinic. The digital clinic to be created consists of a patient’s mobile application and a specialist's desktop, which are connected to each other. With the development of a fully functional and multidisciplinary digital solution, we will reduce migraine sufferers’ burden, improve their quality of life and lead to optimisation of healthcare resources.

Currently, there we have a prototype of the Migrevention digital headache clinic which has passed a clinical pilot study at the University of Tartu Hospital.

Project result

By the end of the project, a designed specialist's desktop/toolbox, patient mobile application, access to specialist care in primary care, a CE marking and registration as an MDR-Class 1 device, 2/3 of the MDR-Class 2 standardization procedure and impact assessment are ready.

Project main progress

Project period 01.06.2021-31.08.2021:

• a seminar introducing the project held on 16.06.2021. The seminar took place via the Zoom platform

• preparation and start of work for adding various features and automatic testing

Project period 01.09.2021-31.11.2021

• we hired a quality manager and started filling MDR class I documents

• we participated in EAS seminar and Katrina Laks talked about Migrevention Digital Headache Clinic

• Green ICT project was mentioned in foundME and EU-Startup articles

Project period 01.12.2021-28.02.2022

• we continued filling MDR class I document

• we participated in EXPO 2020, Dubai

• we have helped over 3700 migraine patients and we have over 3300 webinar viewers

Project period 01.03.2022-31.05.2022

• B2B clinic for GPs (preparing B2B sale process)

• we continued previous development and implementations

• MDR class I registration

Project period 01.06.2022-31.08.2022

• B2B clinic for GPs and hospitals (B2B sale process)

• we continued previous development and implementations

• UX/UI changes

• we continued filling MDR class II documentation

Project period 01.09.2022-30.11.2022

• eID authentication enabled (specialist and admin users). All Estonian clinic personnel have to log in using eID authentication

• Quality Manual corrections and validation

• Internal assessment of the company's compliance as a medical device manufacturer

• Enabling episode days, analgesics, pain graphs and calendar view of patient’s episodes in Patient Manager

Project period 01.12.2022-28.02.2023

• The quality management system is established and documented

• The IEC 62304 standard software development process and associated risk analysis have been carried out

• Necessary developments and security testing have taken place

Project partners

Estonia

• Tartu University Hospital

• Estonian Headache Society

• Estonian Migraine and Headache Patients Association.

United Kingdom

• Oxford University Hospitals Trust and its associated payer (Oxfordshire CCG)

Ireland

• Beaumont Hospital, Dr. Martin Ruttledge

Norway

• Department of Neuromedicine and Movement Science, NTNU, Norwegian University of Science and Technology, Professor Erling Andreas Tronvik, MD, PhD

• Department of Neurology and Neurophysiology, St.Olavs University Hospital, Professor Erling Andreas Tronvik, MD, PhD

Project contacts